Search results
MD Anderson Research Highlights: EHA 2024 Special | Newswise
Newswise· 10 hours agoThe University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research, and prevention. Thes
I’m an oncologist. Here’s what I advised my mom after her cancer diagnosis. | Expert Opinion
Philly.com· 6 days agoQ: My mother-in-law was recently diagnosed with cancer. What steps should patients like her take to...
Small Business - Picayune Item | Picayune Item
The Picayune Item· 7 days agoHONG KONG and SHANGHAI and FLORHAM PARK, N.J., June 06, 2024 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that it has initiated Phase I clinical trial of its menin inhibitor HMPL-506 in
Hope in Oncology: Where Art and Science Collide
Medscape· 1 day agoFollowing a stem cell transplant for leukemia, Carlos had developed a life-threatening case of graft-vs-host disease. "I have hope things will get...
2024 Warren Alpert Foundation Prize Honors Four Pi | Newswise
Newswise· 2 days agoThe 2024 Warren Alpert Foundation Prize has been awarded to four scientists whose transformational discoveries led to the creation of chimeric antigen receptor (CAR) T cells, a treatment that ...
AbbVie's (ABBV) Ovarian Cancer Therapy Meets Study Goal
Zacks via Yahoo Finance· 6 days agoData from a mid-stage study shows that treatment with AbbVie's (ABBV) Elahere achieves an objective...
Thomas Tray Sells 1,093 Shares of Incyte Co. (NASDAQ:INCY) Stock
ETF DAILY NEWS· 1 day agoIncyte Co. (NASDAQ:INCY – Get Free Report) insider Thomas Tray sold 1,093 shares of the stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $58.91, for ...
Teen Becomes Temporarily Paralyzed After 2 Insect Bites: 'Something Was Very Wrong'
People via Yahoo News· 6 days agoAfter being infected by a virus that caused his body to attack itself, Kellen Knutson was partially...
FDA Approves Imetelstat for Rare Low-Risk Blood Cancer
Medscape· 6 days agoThe approval for the first-in-class agent is "potentially practice changing" given the lack of treatment options for transfusion-dependent lower-risk MDS patients.
Cullen Capital Management LLC Reduces Stake in Amgen Inc. (NASDAQ:AMGN)
ETF DAILY NEWS· 1 day agoCullen Capital Management LLC lowered its holdings in Amgen Inc. (NASDAQ:AMGN – Free Report) by 50.9% during the fourth quarter, according to its most recent disclosure with the Securities and ...